Clinical development and future perspective of biological agents

研究成果: Article

抄録

Biological agents targeting against a series of pro-inflammatory cytokines have provided an enormous impact on the therapeutic management on inflammatory disorders such as rheumatoid arthritis. Clinical development of biological agents in Japan, particularly, TNF inhibitors, has been reviewed in this paper, and future perspective is discussed.

元の言語English
ページ(範囲)1185-1188
ページ数4
ジャーナルNippon rinsho. Japanese journal of clinical medicine
65
発行部数7
出版物ステータスPublished - 2007 7
外部発表Yes

Fingerprint

Biological Factors
Rheumatoid Arthritis
Japan
Cytokines
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

これを引用

@article{b188ec1cd2834da186601a3ccd1ee537,
title = "Clinical development and future perspective of biological agents",
abstract = "Biological agents targeting against a series of pro-inflammatory cytokines have provided an enormous impact on the therapeutic management on inflammatory disorders such as rheumatoid arthritis. Clinical development of biological agents in Japan, particularly, TNF inhibitors, has been reviewed in this paper, and future perspective is discussed.",
author = "Tsutomu Takeuchi",
year = "2007",
month = "7",
language = "English",
volume = "65",
pages = "1185--1188",
journal = "Nihon rinsho. Japanese journal of clinical medicine",
issn = "0047-1852",
publisher = "Nipponrinsho Co., Inc.",
number = "7",

}

TY - JOUR

T1 - Clinical development and future perspective of biological agents

AU - Takeuchi, Tsutomu

PY - 2007/7

Y1 - 2007/7

N2 - Biological agents targeting against a series of pro-inflammatory cytokines have provided an enormous impact on the therapeutic management on inflammatory disorders such as rheumatoid arthritis. Clinical development of biological agents in Japan, particularly, TNF inhibitors, has been reviewed in this paper, and future perspective is discussed.

AB - Biological agents targeting against a series of pro-inflammatory cytokines have provided an enormous impact on the therapeutic management on inflammatory disorders such as rheumatoid arthritis. Clinical development of biological agents in Japan, particularly, TNF inhibitors, has been reviewed in this paper, and future perspective is discussed.

UR - http://www.scopus.com/inward/record.url?scp=34548152756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548152756&partnerID=8YFLogxK

M3 - Article

C2 - 17642230

AN - SCOPUS:34548152756

VL - 65

SP - 1185

EP - 1188

JO - Nihon rinsho. Japanese journal of clinical medicine

JF - Nihon rinsho. Japanese journal of clinical medicine

SN - 0047-1852

IS - 7

ER -